Triumvira Immunologics Canada
Triumvira Immunologics, based in Hamilton, ON, is a biotechnology company focused on developing innovative T-cell therapies to combat life-threatening cancers. Utilizing their proprietary T-cell Antigen Coupler (TAC) technology, they aim to enhance the immune response in patients with difficult-to-treat tumors through natural T-cell activation and signaling properties.
The company is committed to building a robust pipeline of TAC-based therapeutic candidates, employing both autologous and allogeneic manufacturing approaches. With broad applicability across various liquid and solid tumors, Triumvira Immunologics leverages advanced manufacturing technologies to ensure optimum product quality and efficacy in cancer treatment.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.